Otsuka and Avanir to Help Start an Alzheimer’s Assistants Training Program in New Jersey
Seizure-Like Brain Activity May Contribute to Alzheimer’s Development, Study Reports
June 1, 2017
$1.7 Million NIH Grant to Fund Pain Therapeutics’ Study of PTI-125 as Candidate for Alzheimer’s Treatment
June 7, 2017
Otsuka America Pharmaceutical and Avanir Pharmaceuticals are working with southern New Jersey educational administrators to create specialists who can help Alzheimer’s patients and their families navigate the care continuum.
